These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27578463)

  • 1. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence.
    Dages KN; Sofola-James O; Sehanobish E; Regula P; Chen CC; Chiarella SE; Divekar RD; Cohen HW; Jerschow E
    J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3662-3669.e2. PubMed ID: 37541619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
    Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
    Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
    White AA; Stevenson DD
    Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.
    Bochenek G; Szafraniec K; Kuschill-Dziurda J; Nizankowska-Mogilnicka E
    Respir Med; 2015 May; 109(5):588-95. PubMed ID: 25820158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E
    Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
    Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
    Park H; Choi Y; Jung CG; Park HS
    Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
    Saff RR; Banerji A
    Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
    Valero A; Sánchez-López J; Bartra J; Serrano C; Muñoz-Cano R; Roca J; Picado C
    Int Arch Allergy Immunol; 2011; 156(2):221-3. PubMed ID: 21597303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and aspirin desensitization in Thai patients with a suggestive history of NSAID-exacerbated respiratory disease.
    Wongsa C; Sompornrattanaphan M; Tantilipikorn P; Thongngarm T
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):247-253. PubMed ID: 31677617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
    Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug hypersensitivity in adults and the factors associated with asthma.
    Karakaya G; Celebioglu E; Kalyoncu AF
    Respir Med; 2013 Jul; 107(7):967-74. PubMed ID: 23643317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.